Dense cholesterol mismatch is linked to higher death risk
In the US cohort, a larger mismatch was linked to 15% higher all-cause mortality per standard deviation, a measure of statistical spread.
16,992 participants
Limit: Small, dense LDL cholesterol was estimated with an equation rather than measured directly
Edited by Boris Djordjevic · AgingResearch.News
In an observational study, researchers analyzed 16,992 US adults and 8,252 Chinese adults across stages of cardiovascular-kidney-metabolic syndrome, involving heart, kidney and metabolic health. They estimated cholesterol in small, dense low-density lipoprotein (LDL) particles and assessed its mismatch with overall LDL cholesterol.
Higher estimated small, dense LDL cholesterol, at a given estimated cholesterol level in larger, more buoyant LDL particles, was linked to advanced syndrome in both cohorts. Greater mismatch was also linked to advanced syndrome. In the Chinese cohort, higher estimated small, dense LDL cholesterol at a given larger-particle level was linked to new cardiovascular disease. The mismatch’s association with new cardiovascular disease weakened after accounting for initial syndrome stage. Each standard deviation increase in mismatch was associated with 23% higher all-cause mortality in China, and 15% higher all-cause mortality and 20% higher cardiovascular mortality in the US.
Why it matters
For cardiovascular-kidney-metabolic health, the authors suggest that the mismatch may reflect differences within LDL cholesterol associated with adverse outcomes.
Caveats
This observational study could not determine cause and effect. Small, dense LDL cholesterol levels were estimated using an equation rather than measured directly.
- Lipid and ceramide metabolism
- Cardiovascular-kidney-metabolic syndrome
- Cardiovascular disease
- Estimated large buoyant low-density lipoprotein cholesterol
- Estimated small dense low-density lipoprotein cholesterol
- Humans
The paper
Capital Medical University
Diabetes, Obesity & Metabolism, Oct 25, 2026
